Jake Chabon

73 posts

Jake Chabon banner
Jake Chabon

Jake Chabon

@JakeChabon

Developing novel blood-based cancer diagnostic assays | CEO @ForesightDx | former PhD @StanfordMed | #ctdna #LiquidBiopsy #MRD

Denver, CO Katılım Ocak 2020
163 Takip Edilen285 Takipçiler
Jake Chabon
Jake Chabon@JakeChabon·
I am honored Dr. Horning has joined our team. She brings significant experience and a shared belief that more sensitive #MRD assays can improve clinical decision making. We look forward to her contributions to @ForesightDx as we realize our vision for improved patient care.
Foresight Diagnostics Inc.@ForesightDx

We’re pleased to announce the addition of Sandra Horning, MD to the Foresight Diagnostics Scientific Advisory Board. A seasoned clinician and biopharmaceutical executive, Dr Horning brings a keen interest in clinical MRD utilization. foresight-dx.com/news/foresight… #lymphoma

English
0
0
0
0
Jake Chabon retweetledi
Foresight Diagnostics Inc.
Foresight Diagnostics Inc.@ForesightDx·
We’re honored to be named a finalist for the CBSA Rising Star award and look forward to seeing members of the Colorado life science community at the 2021 Colorado BioScience Innovation Forum and Annual Awards Celebration. bit.ly/3nN2B2G #CoBioScience @cobioscience
Foresight Diagnostics Inc. tweet media
English
2
1
5
0
Jake Chabon retweetledi
Foresight Diagnostics Inc.
Foresight Diagnostics Inc.@ForesightDx·
A major advance in 1st line #DLBCL care and the first in 20 years was reported in the POLARIX trial showing improved PFS vs. standard of care. Along with our PhasED-Seq #ctDNA platform that detects #MRD, we are improving the lives of #lymphoma patients. bit.ly/3fUc7fH
Graham Collins@graham74GC

POLARIX study meets primary endpoint. Press release: R-CHP+Pola had superior investigator assessed PFS compared with R-CHOP in 1st line high risk DLBCL. A new standard of care in DLBCL? Has R-CHOP really been beaten? Can’t wait to see the data! #lymsm roche.com/de/media/relea…

English
0
2
8
0
Jake Chabon
Jake Chabon@JakeChabon·
The paper describing PhasED-Seq, the key #ctDNA technology enabling our ultra-sensitive #liquidbiopsy #MRD platform was published today in @NatureBiotech! The paper has been a labor of love & we are so grateful to the patients and their families for participating in this study.
Foresight Diagnostics Inc.@ForesightDx

Today we published data demonstrating the utility of our PhasED-Seq #ctDNA platform for detecting #MRD in B-cell #lymphoma patients in @NatureBiotech. Our highly sensitive approach finds relapses that current methods overlook. For more details see our PR: globenewswire.com/news-release/2…

English
1
3
11
0
Jake Chabon retweetledi
Pejman Nozad
Pejman Nozad@pejmannozad·
Finally we can reveal this! 100-times more sensitive than existing liquid biopsy approaches which improves the lives of cancer patients. We are so excited to announce our investment in Foresight! @ForesightDx @CivilizationVC @BluebirdLifeSci @pearvc
Foresight Diagnostics Inc.@ForesightDx

Excited to come out of stealth and announce our $12.5M #SeriesA financing! We’re on a mission to improve the lives of cancer patients with our novel #LiquidBiopsy #MRD testing platform. Thanks to our investors @CivilizationVC @BluebirdLifeSci & @pearvc. prnewswire.com/news-releases/…

English
0
7
33
0

Keşfet

@ForesiteCapital @CivilizationVC @BluebirdLifeSci @pearvc @agent_capital @Stanford @CUSystem @Nature